Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-06

Clinical Trial Update: Comparison of Mean Duration of Post Operative Analgesia Following QL-2 Block vs QL-3 Block Using Ropivacain 0.25% in Patients Undergoing Unilateral Inguinal Hernia Repair [NA]

View source ↗

Summary

A completed clinical trial comparing mean duration of postoperative analgesia between QL-2 and QL-3 blocks using ropivacaine 0.25% in unilateral inguinal hernia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Quaid-e-Azam Medical College | Conditions: Inguinal Hernia Unilateral | NA | Status: COMPLETED